Roche

ROCHE NEWSROOM (43 press releases)

Advanced Filtering & Sorting Options:

Archive by Year: All 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012

Banco Santander to sell portfolio of residential properties to Cerberus affiliate for 1.535 billion euros

PRESS RELEASE -- 20, September 2018

Portfolio comprises 35,700 residential properties, including parking and storage. MADRID, 20-Sep-2018 — /EuropaWire/ — Banco Santander has reached an agreement with an affiliate of Cerberus Capital Management, L.P. (“Cerberus”) for the sale of a portfolio of residential properties for 1.535 billion … Read the full press release →

Roche’s phase III CAPSTONE-2 study showed superior efficacy of baloxavir marboxil in reducing influenza symptoms in people at high risk of complications from the flu

PRESS RELEASE -- 18, July 2018

Baloxavir marboxil – an investigational oral, single-dose antiviral – is the first flu medicine with a novel proposed mechanism of action in nearly 20 years and to demonstrate significant efficacy in high-risk patients Influenza, or “flu,” represents a serious threat … Read the full press release →

Roche’s Tecentriq in combination with Avastin receives FDA Breakthrough Therapy Designation as initial treatment for advanced or metastatic hepatocellular carcinoma

PRESS RELEASE -- 18, July 2018

BASEL, 18-Jul-2018 — /EuropaWire/ — Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab) as an initial (first-line) treatment for people with advanced … Read the full press release →